AI Summary
This article discusses the development of stimuli-responsive polymeric nanocarriers that can accelerate on-demand drug release to target and treat glioblastoma, a type of aggressive brain cancer. These nanocarriers can be triggered by specific stimuli to release the drug directly to the tumor site, increasing efficiency and reducing potential side effects. This research has significant implications for improving targeted drug delivery and treatment options for glioblastoma patients.